neuropsychopharmacology

Latest

neuropsychopharmacology

This shows the shadow of a man in a tunnel

Featured Neuroscience Open Neuroscience Articles Psychology

·April 29, 2020

Drug reduces risk of pedophiles re-offending

Degarelix, a drug that reduces testosterone levels, shows potential in the treatment of pedophilic disorder. Men with a history of child sexual abuse who took the drug had reduced overall sexual desire and decreased attraction toward children, with noticeable effects within two weeks. Read More

This shows fish and the structure of NRF2

Featured Neuroscience Psychology

·April 13, 2020

Discovery of a drug to rescue winter depression-like behavior

Fish model study found a potential target for the treatment of seasonal affective disorder (SAD). Researchers implicated NRF2 in seasonal depression and reported celastrol may help in the treatment of SAD. Read More

This shows a brain and a swirly background

Brain Cancer Featured Neuroscience Psychology

·February 2, 2020

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

A single dose of the psychedelic psilocybin reduces depression, anxiety, and feelings of hopelessness in cancer patients for 12 months after the drug is administered. Read More

This shows a psychedelic face and flowers

Featured Neuroscience Psychology

·January 28, 2020

Could psychedelics help treat mental health and resolve the climate crisis?

Numerous recent studies claim psychedelics, such as psilocybin, can help treat a range of mental health problems from depression to PTSD. Researchers investigate how psychedelics can help us become more "nature-connected" and increase a sense of environmental responsibility. Read More

This shows two heads and a swirly background

Featured Neuroscience Psychology

·January 20, 2020

New research confirms lingering mood benefit of psychedelics

Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness, after the effect of the drug has worn off. Read More

This shows psychedelic swirls around a person's head

Featured Neuroscience Psychology

·January 17, 2020

Psychedelic drugs could help treat PTSD

Backing up previous research, a new study reveals psychedelics can have beneficial effects for treating PTSD when combined with traditional trauma-focused psychotherapy. Findings suggest MDMA assisted therapy is significantly more effective at treating patients with persistent PTSD than psychotherapy alone. Read More

Featured Neuroscience Psychology

·December 11, 2019

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Researchers have distinguished two different molecular pathways responsible for addiction and the prosocial feelings generated by MDMA. The findings could lead to novel treatments for psychiatric disorders marked by withdrawal and social awkwardness. Read More

Featured Neuroscience Open Neuroscience Articles Psychology

·September 20, 2019

Common antidepressant may not reduce depression symptoms, but does reduce anxiety

Sertraline (Zoloft), a commonly prescribed SSRI antidepressant, may not be as effective at treating depression within 6 weeks as previously thought. However, the drug is effective for treating anxiety symptoms. Read More

Featured Neuroscience Psychology

·September 1, 2019

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'. Read More

Featured Neuroscience Psychology

·July 31, 2019

Ketamine isn’t an opioid and treats depression in a unique way

A new study clarifies the mechanism behind how ketamine works as an antidepressant. Researchers say there is evidence to suggest ketamine binds to NMDA receptors, instead of opioid receptors. Reducing the belief that ketamine is an opioid may make patients with depression more open to using the treatment. Read More

This shows a person with pills in their hand

Featured Neurology Neuroscience Open Neuroscience Articles Psychology

·June 25, 2019

Common antidepressants interact with opioid med to lessen pain relief

SSRI antidepressants, such as Prozac and Paxil, interact with opioid medications to make them less effective at providing relief from chronic pain. Tramadol relies on activation of the CYP2D6 enzyme to control pain, but SSRIs inhibit this enzyme. Researchers suggest prescribing different classes of antidepressants which do not suppress the enzyme may benefit those in need of opioid medications. Alternatively, non-opioid pain killers should be considered for those who can not switch from SSRIs. Read More

Featured Neuroscience Psychology

·June 10, 2019

Safe to breastfeed while on bipolar meds? Jury’s still out

Previous research into the effects of lithium exposure via breastmilk are poorly designed and sparse, researchers report. Until more research is done, mothers and babies should be reviewed on a case-by-case basis for lithium continuation, as discontinuing the medication could pose a significant risk for both child and parent. Read More

1 2 3 … 12